FDA approvedGH axisMetabolic

Sermorelin

GHRH(1-29) / Geref

The original FDA-approved GHRH analogue. Stimulates natural GH production through your own pituitary gland. Most natural approach to growth hormone optimization available.

Evidence

Phase III / FDA approved

Routes

injectable

Available since

FDA approved 1997. Off-patent and widely compounded since approximately 2008.

Mechanism of action

Identical to the first 29 amino acids of natural GHRH. Binds pituitary GHRH receptors to stimulate GH production and release. Very short half-life of 10–20 minutes means it creates a natural, physiologic GH pulse rather than a sustained elevation.

Effects in the body

Sermorelin tells your pituitary to produce more growth hormone using your body's own signaling system. Unlike direct GH injections, it preserves the natural pulsatile rhythm and the pituitary's ability to self-regulate.

Pros & cons (from the literature)

Pros

FDA-approved — highest regulatory standing available
Extensive clinical safety and efficacy data
Off-patent and widely compounded — most affordable GH peptide
Widely prescribed by licensed US physicians
Preserves natural GH physiology and pulsatility

Cautions

Very short half-life requires multiple daily injections or strategic bedtime dosing
Less potent GH elevation than CJC-1295/Ipamorelin combination
May lose effectiveness over time if receptor sensitivity decreases
Requires cold storage and careful handling

Protocol summary (from published research)

200–300 mcg subcutaneous injection at bedtime to align with natural GH release rhythms. Often studied in combination with Ipamorelin. Typical research cycles 3–6 months continuous.

Dosing ranges reproduced from published research literature. Not a prescription, not medical advice.

FDA & regulatory status

FDA-approved for pediatric growth hormone deficiency (brand name: Geref — now discontinued). Off-patent and widely compounded off-label for adults by licensed physicians. One of the most prescribed peptides in US longevity medicine.

Evidence base

Full FDA approval data package completed. Decades of clinical use data. Well-characterized safety and efficacy profile across multiple patient populations.

Primary research sources

Peer-reviewed literature referenced throughout this profile is drawn from PubMed, Cell Metabolism, and clinical trial registries cited in the evidence base above.

Expert perspective — Dr. Alex Tatem, Urologist

Dr. Alex Tatem is a board-certified Urologist and Men's Health Specialist who has studied peptides for 12 years. Videos featured for educational purposes. ThePeptide.expert is an independent platform.

Dr. Tatem explains why Sermorelin is considered a safer alternative to synthetic HGH — covering its sleep benefits, skin health support, mild fat loss, and lean muscle properties. Unlike direct HGH, Sermorelin works with your body's natural regulatory system.

Important. ThePeptide.expert summarizes published research. We are not a pharmacy, do not prescribe, and make no therapeutic claims. Regulatory status varies by jurisdiction.